Silverarc Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Silverarc Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-131,151	Closed	-$1.28M	–	89
2022 Q1	$1.28M	Buy	131,151 +2,569	+2%	+$25K	0.53%	47
2021 Q4	$1.25M	Buy	128,582 +18,542	+17%	+$180K	0.51%	51
2021 Q3	$1.07M	Sell	110,040 -263,235	-71%	-$2.54M	0.61%	51
2021 Q2	$3.6M	Buy	+373,275	New	+$3.65M	1.61%	19

Other funds holding MSAC

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Silverarc Capital Management's MSAC Position: Q2 2022 in Review

Silverarc Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q2 2022, closing a stake of 131,151 shares — an estimated $1.28M sold.

Silverarc Capital Management first reported a position in MSAC in Q2 2021 and held it in 4 quarters. The position peaked at $3.6M in Q2 2021. 54 funds tracked by Wall St. Rank hold MSAC as of Q2 2022.

Silverarc Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q2 2022 after selling out during the quarter.
Silverarc Capital Management sold 131,151 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q2 2022, an estimated $1.28M.
Silverarc Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 4 quarters.
Silverarc Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $3.6M in Q2 2021.
54 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q2 2022.

Based on Silverarc Capital Management's 13F filing for Q2 2022, filed 25 Jul 2022.